Delivery Order HHSN271201700016I-75N95019F00091

Award Date 9/1/19
Potential Completion Date 8/31/21
Potential Value $1.2M
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and...
This is a $2,561,491.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the IIT Research Institute, a non-profit research arm of the Illinois Institute of Technology. The contract supports preclinical drug testing services, including pharmacology, toxicology, and safety testing, to generate data for Investigational New Drug applications across therapeutic areas such as cancer, neurology, and...
This is a $2,567,101.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to IIT Research Institute, a non-profit division of Illinois Institute of Technology. The contract is for preclinical drug testing services, including pharmacology, toxicology, and safety evaluations, to support Investigational New Drug applications across therapeutic areas such as cancer, neurology, and neglected diseases. The...
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the IIT Research Institute, a non-profit organization and the research arm of the Illinois Institute of Technology. The $789,821.36 contract provides non-clinical safety assessment of the drug candidate BPN14770 to support the pediatric population with Fragile X Syndrome. This order falls under the broader...
This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $913,177 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, operating as the research and programs division of the Illinois Institute of Technology, will conduct three-month subcutaneous toxicity studies in dogs and mice to support the Center's drug development programs. Performance will...
This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...
This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value...

This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to IIT Research Institute, a non-profit research and technology development organization, to conduct non-clinical safety assessments of acoziborole (SCYX-7158) to support human African trypanosomiasis (HAT) drug development. The $1,156,165.39 delivery order is under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" indefinite delivery/indefinite quantity contract, which enables the NIH to leverage IIT Research Institute's preclinical drug testing capabilities on an as-needed basis. No set-aside designation was used. As the parent organization, the Illinois Institute of Technology has a history of providing research, prototypes, technologies, and educational services to federal agencies through contracts and grants.

Generated 4/16/24, 5:11 PM